InsiderClue
Stocks · Health care · Services-Commercial Physical & Biological Research

Charles River Laboratories

CRL Clue Score34
United States Fiscal year ends December CIK 0001100682 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

19
Insider
Date
Role
Action
Shares
Price
Amount
James C Foster
22 Oct 2026
Director
Sold after exercise
24,042
$350.00
$8.41M
Shannon M Parisotto
21 Oct 2026
CEVP, Disc & Safety Assessment
Sold after exercise
2,156
$344.41
$742.55K
Shannon M Parisotto
5 Oct 2026
CEVP, Disc & Safety Assessment
Sold after exercise
981
$308.44
$302.58K
James C Foster
25 Aug 2026
Director
Sold after exercise
33,561
$300.00
$10.07M
Shannon M Parisotto
19 Aug 2026
CEVP, Disc & Safety Assessment
Sold after exercise
2,039
$294.12
$599.71K
Nancy C Andrews
18 Aug 2026
Director
Sold after exercise
573
$285.24
$163.44K
Shannon M Parisotto
11 Aug 2026
CEVP, Disc & Safety Assessment
Sold after exercise
3,714
$279.66
$1.04M
Birgit Girshick
11 Aug 2026
Chief Executive Officer
Sold after exercise
6,500
$279.90
$1.82M
James C Foster
10 Aug 2026
Director
Sold after exercise
28,733
$275.00
$7.90M
Victoria L Creamer
6 Aug 2026
EVP & Chief People Officer
Sold after exercise
4,179
$259.16
$1.08M
Michael Gunnar Knell
6 Aug 2026
SVP, Finance and CAO
Sold after exercise
736
$258.53
$190.28K
Michael Gunnar Knell
6 Aug 2026
SVP, Finance and CAO
Sold after exercise
1,205
$258.53
$311.53K
Michael Gunnar Knell
6 Aug 2026
SVP, Finance and CAO
Sold after exercise
404
$258.53
$104.45K
Michael Gunnar Knell
6 Aug 2026
SVP, Finance and CAO
Sold after exercise
482
$265.17
$127.81K
Michael Gunnar Knell
6 Aug 2026
SVP, Finance and CAO
Sold after exercise
620
$263.94
$163.64K
Michael Gunnar Knell
6 Aug 2026
SVP, Finance and CAO
Sold after exercise
213
$262.37
$55.88K
Michael Gunnar Knell
6 Aug 2026
SVP, Finance and CAO
Sold after exercise
810
$261.45
$211.77K
Michael Gunnar Knell
6 Aug 2026
SVP, Finance and CAO
Sold after exercise
901
$260.63
$234.83K
Michael Gunnar Knell
6 Aug 2026
SVP, Finance and CAO
Sold after exercise
1,274
$259.07
$330.06K
Show all 23 transactions →

What was left out

Form 4 filings counted 59
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 19
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 702,199
History held since 5 Oct 2006